Dupilumab and tezepelumab in severe refractory asthma: new opportunities

Bronchial asthma is a chronic inflammatory condition with increasing prevalence worldwide that may present as heterogeneous phenotypes defined by the T2-mediated pattern of airway inflammation T2-high and T2-low asthma. Severe refractory asthma includes a subset of asthmatic patients who fail to con...

Descripción completa

Detalles Bibliográficos
Autores principales: Ragnoli, Beatrice, Morjaria, Jaymin, Pignatti, Patrizia, Montuschi, Paolo, Barbieri, Mariangela, Mondini, Lucrezia, Ruggero, Luca, Trotta, Liliana, Malerba, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152192/
https://www.ncbi.nlm.nih.gov/pubmed/35655942
http://dx.doi.org/10.1177/20406223221097327

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152192/
https://www.ncbi.nlm.nih.gov/pubmed/35655942
http://dx.doi.org/10.1177/20406223221097327

Ejemplares similares